MedTrace Logo

Potassium Intake-response Trial to Control Hypertension

NCT05758142 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-05-13

Study results available
· View outcomes & findings →

Summary

The Potassium Intake-response Trial to Control Hypertension (PITCH) will test the intake-response relationship between potassium supplementation and blood pressure, which may inform clinical guidelines on the optimal level of potassium supplementation for blood pressure lowering among adults with elevated blood pressure or hypertension and dietary guidelines for population intake.

Conditions

  • Blood Pressure

Interventions

DIETARY_SUPPLEMENT

Potassium Chloride

Oral administration of potassium chloride tablets

OTHER

Placebo

Oral administration of inert placebo tablets

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • Tulane University

    lead OTHER

Principal Investigators

  • Joshua D Bundy, PhD, MPH · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-29
Primary Completion
2024-05-03
Completion
2024-05-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758142 on ClinicalTrials.gov